Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2021 | Rising BioSciences, Inc. acquired OXY THYME Southeast, Inc. | CI |
2019 | Rising BioSciences, Inc. acquired Southern Northern Behavioral Health, Inc. | CI |
Business Summary
Sales per Business
USD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
Oral and Topical Cannabis and Non-cannabis Based Pharmaceuticals
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +377.77% |
Sales per region
USD in Million | 2019 | Weight | 2020 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +377.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Arthur Hall
CEO | Chief Executive Officer | - | - |
Jim DiPrima
DFI | Director of Finance/CFO | 75 | - |
Chief Operating Officer | - | 07/03/19 | |
Gary C. Bernard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jim DiPrima
DFI | Director of Finance/CFO | 75 | - |
Arthur Hall
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 1,059,725,348 | 1,059,725,348 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Rising Biosciences, Inc.
1190 Cleveland Road
44870, Sandusky
+
Sector
1st Jan change | Capi. | |
---|---|---|
0.00% | 1.06K | |
+12.81% | 8.1B | |
+0.40% | 6.54B | |
+2.62% | 5.31B | |
+2.44% | 4.46B | |
+11.24% | 4.32B | |
+12.52% | 3.69B | |
+24.28% | 3.25B | |
-3.68% | 3.04B | |
+31.01% | 1.99B |
- Stock Market
- Equities
- RBII Stock
- Company Rising BioSciences, Inc.